Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals.

The smooth-muscle tone of pial, middle, and anterior cerebral arteries from humans, cats, and pigs, respectively, was studied in vitro with respect to the effects of capsaicin and various peptides which are present in local perivascular nerves. Neuropeptide Y (NPY) caused concentration-dependent, potent contractions of the cerebral vessels both in the presence and in the absence of endothelium. In contrast to the response to noradrenaline (NA) and K+, the NPY effect was not altered by changes in the extracellular Ca++ concentration. The relaxant action of the calcium antagonist nifedipine on NPY-evoked contraction of cerebral arteries was not inhibited by a Ca++-deficient medium or by a high-Ca++ medium. Calcitonin gene-related peptide (CGRP), substance P (SP), and capsaicin caused relaxation of precontracted cerebral arteries with an intact endothelium. Calcitonin gene-related peptide was the most potent dilatory agent, and removal of the endothelium did not change the CGRP response. In contrast, the ability of SP to cause relaxation was abolished after removal of the endothelium. Capsaicin, which activates sensory nerves, induced long-lasting relaxation in both the presence and absence of endothelium. In conclusion, in contrast to earlier reported data, the contractile effect of NPY seems to be largely independent of extracellular Ca++, while NA- and K+-induced contractions are dependent on extracellular Ca++. The present results suggest that the relaxant effect of nifedipine on cerebral blood vessels may involve actions other than inhibition of Ca++ influx. The relaxant effect of capsaicin is likely to be induced by release of CGRP rather than SP. The potent effects of these peptides on human pial arteries suggest that neuropeptides may be involved in the control of cerebral blood flow in man.

[1]  A. Franco‐Cereceda,et al.  Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig. , 1987, European journal of pharmacology.

[2]  J. Pernow,et al.  Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro. , 1987, European journal of pharmacology.

[3]  G. Rinaldi,et al.  Dissociation between calcium influx blockage and smooth muscle relaxation by nifedipine in spontaneously hypertensive rats. , 1987, Circulation research.

[4]  P. Emson,et al.  Nerve Fibers Containing Neuropeptide Y in the Cerebrovascular Bed: Immunocytochemistry, Radioimmunoassay, and Vasomotor Effects , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  A. Sollevi,et al.  Elevations of neuropeptide Y‐like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig , 1987, Acta anaesthesiologica Scandinavica.

[6]  T. Godfraind Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification). , 2009, Acta pharmacologica et toxicologica.

[7]  P. Hjemdahl,et al.  Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. , 2008, Clinical physiology.

[8]  J. Pernow,et al.  Neuropeptide Y constricts human skeletal muscle arteries via a nifedipine-sensitive mechanism independent of extracellular calcium? , 1986, Acta physiologica Scandinavica.

[9]  J. Mcculloch,et al.  Calcitonin gene-related peptide: functional role in cerebrovascular regulation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. St.-Pierre,et al.  The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heart , 1986, Peptides.

[11]  A. Saria,et al.  Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices , 1986, Neuroscience Letters.

[12]  A. Sollevi,et al.  Frequency- and reserpine-dependent chemical coding of sympathetic transmission: Differential release of noradrenaline and neuropeptide Y from pig spleen , 1986, Neuroscience Letters.

[13]  G. Fried,et al.  NPY--a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation? , 1986, Acta physiologica Scandinavica.

[14]  L. Edvinsson Functional role of perivascular peptides in the control of cerebral circulation , 1985, Trends in Neurosciences.

[15]  P. Hjemdahl,et al.  Co-release of neuropeptide Y and catecholamines during physical exercise in man. , 1985, Biochemical and biophysical research communications.

[16]  B. Fredholm,et al.  Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat , 1985, Neuroscience Letters.

[17]  F. Sundler,et al.  Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries , 1985, Neuroscience Letters.

[18]  E. Högestätt,et al.  Influence of extracellular calcium and nifedipine on α1‐and α2‐adrenoceptor‐mediated contractile responses in isolated rat and cat cerebral and mesenteric arteries , 1985 .

[19]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[20]  E. Högestätt,et al.  On the mechanism of action of calcium antagonists. , 2009, Acta medica Scandinavica. Supplementum.

[21]  J. Pernow,et al.  Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation , 1984, Neuroscience Letters.

[22]  F. Schon,et al.  PRESENCE OF NEUROPEPTIDE Y IN HUMAN CIRCLE OF WILLIS AND ITS POSSIBLE ROLE IN CEREBRAL VASOSPASM , 1984, The Lancet.

[23]  B. Weir,et al.  A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys. Part 2: Pathological findings. , 1984, Journal of neurosurgery.

[24]  P. Emson,et al.  Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the cat , 1983, Neuroscience Letters.

[25]  B. Hindfelt,et al.  Prostaglandin metabolism and prostacyclin in cerebral vasospasm. , 1983, General pharmacology.

[26]  L. Edvinsson,et al.  Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. , 1983, Acta physiologica Scandinavica.

[27]  T. Hökfelt,et al.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. , 1982, Acta physiologica Scandinavica.

[28]  J. Mcculloch,et al.  Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. , 1981, The Journal of physiology.

[29]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[30]  J. Church,et al.  Calcium antagonistic drugs. Mechanism of action. , 1980, Canadian journal of physiology and pharmacology.

[31]  S. Moncada,et al.  Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. , 1979, British journal of clinical pharmacology.

[32]  Smith Hs Letter: Fortified flour. , 1975 .